The estimated Net Worth of Joseph H Crabb is at least $659 mil dollars as of 26 November 2018. Dr Crabb owns over 47,500 units of Immucell stock worth over $537,593 and over the last 21 years he sold ICCC stock worth over $66,602. In addition, he makes $54,982 as VP & Chief Scientific Officer at Immucell.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr D ICCC stock SEC Form 4 insiders trading
Dr has made over 14 trades of the Immucell stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 47,500 units of ICCC stock worth $80,750 on 26 November 2018.
The largest trade he's ever made was exercising 47,500 units of Immucell stock on 26 November 2018 worth over $80,750. On average, Dr trades about 7,263 units every 282 days since 2004. As of 26 November 2018 he still owns at least 141,845 units of Immucell stock.
You can see the complete history of Dr Crabb stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Joseph H. Crabb Ph.D. biography
Dr. Joseph H. Crabb Ph.D. is the VP & Chief Scientific Officer at Immucell.
What is the salary of Dr D?
As the VP & Chief Scientific Officer of Immucell, the total compensation of Dr D at Immucell is $54,982. There are 5 executives at Immucell getting paid more, with Michael F. Brigham having the highest compensation of $354,272.
How old is Dr D?
Dr D is 66, he's been the VP & Chief Scientific Officer of Immucell since . There are no older and 10 younger executives at Immucell.
What's Dr D's mailing address?
Joseph's mailing address filed with the SEC is PO BOX 746, , OQUOSSOC, ME, 04964.
Insiders trading at Immucell
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin y Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
What does Immucell do?
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
What does Immucell's logo look like?
Complete history of Dr Crabb stock trades at Immucell
Immucell executives and stock owners
Immucell executives and other stock owners filed with the SEC include:
-
Michael F. Brigham,
Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director -
Michael Brigham,
President, Chief Executive Officer, Treasurer, Secretary, Director -
Bobbi Brockmann,
Vice President - Sales and Marketing, Director -
Elizabeth Williams,
Vice President - Manufacturing Operations -
Elizabeth L. Williams,
VP of Manufacturing Operations -
Dr. Joseph H. Crabb Ph.D.,
VP & Chief Scientific Officer -
Joseph Crabb,
Chief Scientific Officer, Vice President -
David Tomsche,
Chairman of the Board -
Paul Wainman,
Independent Director -
Jonathan Rothschild,
Independent Director -
Steven Rosgen,
Independent Director -
David Cunningham,
Independent Director -
John W. Zinckgraf,
Director of Product Devel. -
A. Gustavo Scaffa,
Sr. Director of Quality -
Elizabeth S. Toothaker,
Director of Fin. & Admin. -
Linda Rhodes,
Director -
Brian L. Pessin,
-
Norman H Pessin,
-
Gloria F Basse,
Director -
Anthony B Cashen,
Director -
Robert C Bruce,
Director -
William H Maxwell,
Director -
Bryan K. Gathagan,